Company: LCTX
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0000950170-25-036309
Chunk: 264

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 8
Chunk 264
---
    $
    179

    $
    —

    Fair value of warrant liability recognized upon issuance in registered direct financing
     
    $
    8,289

    $
    —

    Financed insurance premium
     
    $
    855

    $
    —

    Reconciliation of cash, cash equivalents and restricted cash, end of period:

    Cash and cash equivalents
     
    $
    45,789

    $
    35,442

    Restricted cash included in deposits and other long-term assets    (see Note 13 (Commitments and Contingencies))

    565

    550

    Total cash, cash equivalents, and restricted cash
     
    $
    46,354

    $
    35,992

See accompanying notes to the consolidated financial statements.

101

LINEAGE CELL THERAPEUTICS, INC. AND SUBSIDIARIES